1. Home
  2. LNTH vs ROKU Comparison

LNTH vs ROKU Comparison

Compare LNTH & ROKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • ROKU
  • Stock Information
  • Founded
  • LNTH 1956
  • ROKU 2002
  • Country
  • LNTH United States
  • ROKU United States
  • Employees
  • LNTH N/A
  • ROKU N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ROKU Cable & Other Pay Television Services
  • Sector
  • LNTH Health Care
  • ROKU Telecommunications
  • Exchange
  • LNTH Nasdaq
  • ROKU Nasdaq
  • Market Cap
  • LNTH 7.5B
  • ROKU 8.7B
  • IPO Year
  • LNTH 2015
  • ROKU 2017
  • Fundamental
  • Price
  • LNTH $101.32
  • ROKU $58.46
  • Analyst Decision
  • LNTH Strong Buy
  • ROKU Buy
  • Analyst Count
  • LNTH 6
  • ROKU 22
  • Target Price
  • LNTH $129.83
  • ROKU $94.52
  • AVG Volume (30 Days)
  • LNTH 830.2K
  • ROKU 4.5M
  • Earning Date
  • LNTH 05-01-2025
  • ROKU 05-01-2025
  • Dividend Yield
  • LNTH N/A
  • ROKU N/A
  • EPS Growth
  • LNTH N/A
  • ROKU N/A
  • EPS
  • LNTH 4.36
  • ROKU N/A
  • Revenue
  • LNTH $1,533,910,000.00
  • ROKU $4,112,898,000.00
  • Revenue This Year
  • LNTH $5.74
  • ROKU $13.76
  • Revenue Next Year
  • LNTH $12.27
  • ROKU $12.18
  • P/E Ratio
  • LNTH $23.24
  • ROKU N/A
  • Revenue Growth
  • LNTH 18.32
  • ROKU 18.03
  • 52 Week Low
  • LNTH $61.47
  • ROKU $48.33
  • 52 Week High
  • LNTH $126.89
  • ROKU $104.96
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 55.37
  • ROKU 38.06
  • Support Level
  • LNTH $91.65
  • ROKU $57.03
  • Resistance Level
  • LNTH $104.00
  • ROKU $62.64
  • Average True Range (ATR)
  • LNTH 5.54
  • ROKU 5.07
  • MACD
  • LNTH 0.34
  • ROKU -0.17
  • Stochastic Oscillator
  • LNTH 85.89
  • ROKU 28.53

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About ROKU Roku Inc.

Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 127 billion streaming hours in 2024. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.

Share on Social Networks: